La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « P. Jenner »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
P. J. Wilkinson < P. Jenner < P. Johannsen  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000377 (2009) A. H. Schapira [Royaume-Uni] ; Yves Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; Werner Poewe [Autriche] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne]Perspectives on recent advances in the understanding and treatment of Parkinson’s disease
000604 (2000) L. A. Smith [Royaume-Uni] ; M. G. Jackson [Royaume-Uni] ; C. Bonhomme [France] ; C. Chezaubernard [France] ; K. B. Pearce [Royaume-Uni] ; P. Jenner [Royaume-Uni]Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset
000607 (2000) P. Jenner [Royaume-Uni] ; B.-Y. Zeng [Royaume-Uni] ; L. A. Smith [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] ; B. Tel [Royaume-Uni] ; L. Chancharme [France] ; G. Moachon [France]Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset
000700 (1992) P. Jenner [Royaume-Uni]Parkinson's disease : pathological mechanisms and actions of piribedil
000708 (1991) D. T. Dexter [Royaume-Uni] ; A. Carayon [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; F. R. Wells [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; A. J. Lees [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA
000717 (1990) R. Raisman-Vozari [France] ; J.-A. Girault [États-Unis] ; S. Moussaoui [France] ; C. Feuerstein [France] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Yves Agid [France]Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
000718 (1990) D. T. Dexter [Royaume-Uni] ; A. Carayon ; M. Vidailhet ; M. Ruberg ; F. Agid ; Yves Agid [France] ; A. J. Lees ; F. R. Wells ; P. Jenner ; C. D. MarsdenDecreased ferritin levels in brain in Parkinson's disease
000721 (1988) H. Taquet [France] ; M. Nomoto [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; F. Javoy-Agid [Royaume-Uni] ; A. Mauborgne [France] ; J. J. Benoliel [France] ; C. D. Marsden [Royaume-Uni] ; J. C. Legrand [France] ; Yves Agid [France] ; M. Hamon [France] ; F. Cesselin [France]Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Parkinson disease
3Animal
2Antiparkinson agent
2Blood
2Callithrix jacchus
2Degenerative disease
2Human
2Nervous system diseases
2Proteins
2Treatment
11-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
1Aged
1Aged, 80 and over
1Agonist
1Animals
1Antagonist
1Autopsy
1Biochemical analysis
1Biological activity
1Blood plasma
1Brain
1Callitrichinae
1Cerebrospinal fluid
1Chemotherapy
1Corpus Striatum (metabolism)
1Corpus Striatum (physiopathology)
1Corpus striatum
1D2 Dopamine receptor
1D3 Dopamine receptor
1DARPP-32
1Disability
1Dopamine (metabolism)
1Dopamine (physiology)
1Dopamine agonist
1Dopamine and cAMP-Regulated Phosphoprotein 32
1Dopaminergic lesion
1Dopaminergic neuron
1Dopaminergic pathway
1Dosage form
1Dose activity relation
1Etiopathogenesis
1Experimental disease
1Exploration
1Female
1Ferritin
1Humans
1Hypokinesia
1Inorganic element
1Iron
1Locomotion
1Locus niger
1Male
1Modafinil
1Motor system disorder
1Nerve Tissue Proteins (metabolism)
1Neuroprotective agent
1Neurotoxin
1Nigrostriatal pathway
1Parkinson
1Parkinson Disease, Secondary (metabolism)
1Parkinson’s disease
1Patch
1Percutaneous route
1Pharmacokinetics
1Phosphoprotein
1Phosphoproteins
1Phosphorylation
1Piribedil
1Rats
1Slow release form
1Striatum
1Substantia Nigra (physiology)
1Tyrosine hydroxylase
1autophagy
1depression
1dopamine agonist
1levodopa
1mitochondrial
1neuroprotection
1non‐motor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "P. Jenner" 
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "P. Jenner" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    P. Jenner
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024